- Home
- EIC vs AMRN Comparison
EIC vs AMRN Comparison
Compare EIC & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EIC | AMRN |
|---|---|---|
| Founded | N/A | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 228.8M | 287.9M |
| IPO Year | 2018 | 1998 |
Fundamental Metrics
Financial Performance| Metric | EIC | AMRN |
|---|---|---|
| Price | $9.23 | $13.25 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 3 | 1 |
| Target Price | ★ $12.63 | $12.00 |
| AVG Volume (30 Days) | ★ 93.6K | 47.5K |
| Earning Date | 05-27-2026 | 04-29-2026 |
| Dividend Yield | ★ 13.25% | N/A |
| EPS Growth | N/A | ★ 55.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $181,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.26 |
| P/E Ratio | $9.08 | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $9.17 | $12.96 |
| 52 Week High | $13.55 | $20.90 |
Technical Indicators
Market Signals| Indicator | EIC | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 20.50 | 37.86 |
| Support Level | $9.17 | N/A |
| Resistance Level | $10.14 | $14.50 |
| Average True Range (ATR) | 0.14 | 0.34 |
| MACD | -0.05 | -0.06 |
| Stochastic Oscillator | 7.78 | 18.64 |
Price Performance
Historical ComparisonAbout EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.